The price of Elevation Oncology Inc (NASDAQ: ELEV) closed at $5.01 in the last session, up 0.20% from day before closing price of $5.00. In other words, the price has increased by $+0.01 from its previous closing price. On the day, 1284578 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
We take a closer look at ELEV’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.22 and its Current Ratio is at 21.22. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on March 01, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $7.
On May 30, 2023, SVB Securities Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $5 to $8.
On December 23, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.H.C. Wainwright initiated its Buy rating on December 23, 2021, with a $12 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 243.01M and an Enterprise Value of 190.04M.
Stock Price History:
Over the past 52 weeks, ELEV has reached a high of $5.89, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 3.53, while the 200-Day Moving Average is calculated to be 1.55.
Shares Statistics:
According to the various share statistics, ELEV traded on average about 3.07M shares per day over the past 3-months and 678.47k shares per day over the past 10 days. A total of 42.42M shares are outstanding, with a floating share count of 39.81M. Insiders hold about 18.17% of the company’s shares, while institutions hold 66.17% stake in the company. Shares short for ELEV as of Feb 29, 2024 were 3.61M with a Short Ratio of 1.51, compared to 3.52M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.50% and a Short% of Float of 9.61%.
Earnings Estimates
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.2 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.23, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.18 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.76 and -$0.92 for the fiscal current year, implying an average EPS of -$0.85. EPS for the following year is -$0.89, with 5 analysts recommending between -$0.62 and -$1.3.
